U.S. Food and Drug Administration • Center for Drug Evaluation
and Research |
U.S. Food and Drug Administration • Center for Drug Evaluation
and Research |
 |
Center for Drug Evaluation and Research |
 |
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.5 CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE; ORAL
FIORICET W/ CODEINE
>D> AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN
>A> AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN
ACETAMINOPHEN; CODEINE PHOSPHATE
TABLET; ORAL
CODRIX
>A> + ANDRX PHARMS 500MG;30MG N40441 001 MAR 27, 2003 MAR NEWA
>A> + 500MG;60MG N40488 001 MAR 28, 2003 MAR NEWA
ALFENTANIL HYDROCHLORIDE
INJECTABLE; INJECTION
ALFENTA
>A> AP + AKORN EQ 0.5MG BASE/ML N19353 001 DEC 29, 1986 MAR CAHN
>D> AP + GD SEARLE LLC EQ 0.5MG BASE/ML N19353 001 DEC 29, 1986 MAR CAHN
>D> ALPHA-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID;
NIACINAMIDE; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A
>D> INJECTABLE; INJECTION
>D> CERNEVIT-12
>D> + BAXTER HLTHCARE 11.2
IU/VIAL;125MG/VIAL;60UGM/VIAL;200
IU/VIAL;5.5MG/VIAL;414UGM/VIAL;46MG
/VIAL;17.25MG/VIAL;4.53MG/VIAL;4.14
MG/VIAL;3.51MG/VIAL;3,500 IU/VIAL N20924 001 APR 06, 1999 MAR DISC
>A> @ 11.2
IU/VIAL;125MG/VIAL;60UGM/VIAL;200
IU/VIAL;5.5MG/VIAL;414UGM/VIAL;46MG
/VIAL;17.25MG/VIAL;4.53MG/VIAL;4.14
MG/VIAL;3.51MG/VIAL;3,500 IU/VIAL N20924 001 APR 06, 1999 MAR DISC
AMCINONIDE
OINTMENT; TOPICAL
AMCINONIDE
>A> AB TARO PHARM INDS 0.1% N76367 001 MAR 19, 2003 MAR NEWA
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
CORDARONE
>D> AP + WYETH AYERST 50MG/ML N20377 001 AUG 03, 1995 MAR CAHN
>A> AP + WYETH PHARMS INC 50MG/ML N20377 001 AUG 03, 1995 MAR CAHN
TABLET; ORAL
>D> AB WYETH AYERST 200MG N18972 001 DEC 24, 1985 MAR CAHN
>A> AB WYETH PHARMS INC 200MG N18972 001 DEC 24, 1985 MAR CAHN
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
TABLET; ORAL
>D> ETRAFON 2-10
>D> BP SCHERING 10MG;2MG N14713 007 MAR DISC
>A> @ 10MG;2MG N14713 007 MAR DISC
>D> BP SCHERING 25MG;2MG N14713 004 MAR DISC
>A> @ 25MG;2MG N14713 004 MAR DISC
>D> ETRAFON-FORTE
>D> BP SCHERING 25MG;4MG N14713 006 MAR DISC
>A> @ 25MG;4MG N14713 006 MAR DISC
AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION; ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
>A> AB RANBAXY 200MG/5ML;EQ 28.5MG BASE/5ML N65132 001 MAR 19, 2003 MAR NEWA
>A> AB 400MG/5ML;EQ 57MG BASE/5ML N65132 002 MAR 19, 2003 MAR NEWA
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE;
DEXTROAMPHETAMINE SULFATE
TABLET; ORAL
ADDERALL 12.5
>D> SHIRE LABS 3.125MG;3.125MG;3.125MG;3.125MG N11522 012 AUG 31, 2000 MAR CFTG
>A> AB 3.125MG;3.125MG;3.125MG;3.125MG N11522 012 AUG 31, 2000 MAR CFTG
ADDERALL 15
>D> SHIRE LABS 3.75MG;3.75MG;3.75MG;3.75MG N11522 013 AUG 31, 2000 MAR CFTG
>A> AB 3.75MG;3.75MG;3.75MG;3.75MG N11522 013 AUG 31, 2000 MAR CFTG
ADDERALL 7.5
>D> SHIRE LABS 1.875MG;1.875MG;1.875MG;1.875MG N11522 011 AUG 31, 2000 MAR CFTG
>A> AB 1.875MG;1.875MG;1.875MG;1.875MG N11522 011 AUG 31, 2000 MAR CFTG
>A> DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
>A> AB BARR 1.875MG;1.875MG;1.875MG;1.875MG N40422 005 MAR 19, 2003 MAR NEWA
>A> AB 3.125MG;3.125MG;3.125MG;3.125MG N40422 006 MAR 19, 2003 MAR NEWA
>A> AB 3.75MG;3.75MG;3.75MG;3.75MG N40422 007 MAR 19, 2003 MAR NEWA
AMPRENAVIR
CAPSULE; ORAL
AGENERASE
>D> @ GLAXOSMITHKLINE 50MG N21007 001 APR 15, 1999 MAR CMFD
>A> 50MG N21007 001 APR 15, 1999 MAR CMFD
>D> @ 150MG N21007 002 APR 15, 1999 MAR CMFD
>A> + 150MG N21007 002 APR 15, 1999 MAR CMFD
SOLUTION; ORAL
>D> @ GLAXOSMITHKLINE 15MG/ML N21039 001 APR 15, 1999 MAR CMFD
>A> + 15MG/ML N21039 001 APR 15, 1999 MAR CMFD
>A> APREPITANT
>A> CAPSULE; ORAL
>A> EMEND
>A> MERCK 80MG N21549 001 MAR 26, 2003 MAR NEWA
>A> + 125MG N21549 002 MAR 26, 2003 MAR NEWA
ASPIRIN; BUTALBITAL; CAFFEINE
CAPSULE; ORAL
FIORINAL
>D> AB + NOVARTIS 325MG;50MG;40MG N17534 005 APR 16, 1986 MAR CAHN
>A> AB + WATSON PHARMS 325MG;50MG;40MG N17534 005 APR 16, 1986 MAR CAHN
TABLET; ORAL
>D> AB + NOVARTIS 325MG;50MG;40MG N17534 003 APR 16, 1986 MAR CAHN
>A> AB + WATSON PHARMS 325MG;50MG;40MG N17534 003 APR 16, 1986 MAR CAHN
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE; ORAL
FIORINAL W/CODEINE NO 3
>D> AB + NOVARTIS 325MG;50MG;40MG;30MG N19429 003 OCT 26, 1990 MAR CAHN
>A> AB + WATSON PHARMS 325MG;50MG;40MG;30MG N19429 003 OCT 26, 1990 MAR CAHN
BECLOMETHASONE DIPROPIONATE
AEROSOL, METERED; INHALATION
>D> BECLOVENT
>D> BN GLAXOSMITHKLINE 0.042MG/INH N18153 001 MAR DISC
>A> @ 0.042MG/INH N18153 001 MAR DISC
>D> AEROSOL, METERED; NASAL
>D> BECONASE
>D> BN + GLAXOSMITHKLINE 0.042MG/INH N18584 001 MAR DISC
>A> @ 0.042MG/INH N18584 001 MAR DISC
>D> VANCENASE
>D> BN SCHERING 0.042MG/INH N18521 001 MAR DISC
>A> @ 0.042MG/INH N18521 001 MAR DISC
BISOPROLOL FUMARATE
TABLET; ORAL
ZEBETA
>D> AB LEDERLE 5MG N19982 002 JUL 31, 1992 MAR CAHN
>D> AB + 10MG N19982 001 JUL 31, 1992 MAR CAHN
>A> AB WYETH PHARMS INC 5MG N19982 002 JUL 31, 1992 MAR CAHN
>A> AB + 10MG N19982 001 JUL 31, 1992 MAR CAHN
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
TABLET; ORAL
ZIAC
>D> AB LEDERLE 2.5MG;6.25MG N20186 003 MAR 26, 1993 MAR CAHN
>D> AB 5MG;6.25MG N20186 001 MAR 26, 1993 MAR CAHN
>D> AB + 10MG;6.25MG N20186 002 MAR 26, 1993 MAR CAHN
>A> AB WYETH PHARMS INC 2.5MG;6.25MG N20186 003 MAR 26, 1993 MAR CAHN
>A> AB 5MG;6.25MG N20186 001 MAR 26, 1993 MAR CAHN
>A> AB + 10MG;6.25MG N20186 002 MAR 26, 1993 MAR CAHN
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
SYRUP; ORAL
>D> DIMETANE-DX
>D> AA + ROBINS AH 2MG/5ML;10MG/5ML;30MG/5ML N19279 001 AUG 24, 1984 MAR DISC
>A> @ 2MG/5ML;10MG/5ML;30MG/5ML N19279 001 AUG 24, 1984 MAR DISC
MYPHETANE DX
>D> AA MORTON GROVE 2MG/5ML;10MG/5ML;30MG/5ML N88811 001 JUN 07, 1985 MAR CTEC
>A> AA + 2MG/5ML;10MG/5ML;30MG/5ML N88811 001 JUN 07, 1985 MAR CTEC
CALCITRIOL
INJECTABLE; INJECTION
CALCITRIOL
>A> AP GENSIA SICOR PHARMS 0.001MG/ML N75823 001 MAR 31, 2003 MAR NEWA
>A> AP 0.002MG/ML N75823 002 MAR 31, 2003 MAR NEWA
>A> CARBINOXAMINE MALEATE
>A> TABLET; ORAL
>A> CARBINOXAMINE MALEATE
>A> + MIKART 4MG N40442 001 MAR 19, 2003 MAR NEWA
CEFADROXIL/CEFADROXIL HEMIHYDRATE
FOR SUSPENSION; ORAL
>A> CEFADROXIL
>A> AB RANBAXY EQ 125MG BASE/5ML N65115 001 MAR 26, 2003 MAR NEWA
>A> AB EQ 250MG BASE/5ML N65115 002 MAR 26, 2003 MAR NEWA
>A> AB EQ 500MG BASE/5ML N65115 003 MAR 26, 2003 MAR NEWA
DURICEF
>D> WARNER CHILCOTT EQ 125MG BASE/5ML N50527 002 MAR CFTG
>A> AB EQ 125MG BASE/5ML N50527 002 MAR CFTG
>D> EQ 250MG BASE/5ML N50527 003 MAR CFTG
>A> AB EQ 250MG BASE/5ML N50527 003 MAR CFTG
>D> + EQ 500MG BASE/5ML N50527 001 MAR CFTG
>A> AB + EQ 500MG BASE/5ML N50527 001 MAR CFTG
CEFOXITIN SODIUM
INJECTABLE; INJECTION
MEFOXIN IN PLASTIC CONTAINER
>D> MERCK EQ 20MG BASE/ML N63182 001 JAN 25, 1993 MAR CRLD
>A> + EQ 20MG BASE/ML N63182 001 JAN 25, 1993 MAR CRLD
>D> EQ 40MG BASE/ML N63182 002 JAN 25, 1993 MAR CRLD
>A> + EQ 40MG BASE/ML N63182 002 JAN 25, 1993 MAR CRLD
CEPHALOTHIN SODIUM
INJECTABLE; INJECTION
CEPHALOTHIN SODIUM
>D> AP BRISTOL EQ 1GM BASE/VIAL N62464 001 MAY 07, 1984 MAR CRLD
>A> + EQ 1GM BASE/VIAL N62464 001 MAY 07, 1984 MAR CRLD
>D> AP EQ 2GM BASE/VIAL N62464 002 MAY 07, 1984 MAR CRLD
>A> + EQ 2GM BASE/VIAL N62464 002 MAY 07, 1984 MAR CRLD
>D> AP EQ 4GM BASE/VIAL N62464 003 MAY 07, 1984 MAR CRLD
>A> + EQ 4GM BASE/VIAL N62464 003 MAY 07, 1984 MAR CRLD
>D> KEFLIN
>D> AP + LILLY EQ 1GM BASE/VIAL N50482 001 MAR DISC
>A> @ EQ 1GM BASE/VIAL N50482 001 MAR DISC
>D> AP + EQ 2GM BASE/VIAL N50482 002 MAR DISC
>A> @ EQ 2GM BASE/VIAL N50482 002 MAR DISC
>D> AP + EQ 4GM BASE/VIAL N50482 003 MAR DISC
>A> @ EQ 4GM BASE/VIAL N50482 003 MAR DISC
CLINDAMYCIN HYDROCHLORIDE
CAPSULE; ORAL
CLINDAMYCIN HCL
>A> AB WATSON LABS EQ 300MG BASE N63083 002 MAR 18, 2003 MAR NEWA
COPPER
INTRAUTERINE DEVICE; INTRAUTERINE
COPPER T MODEL TCU 380A
>A> + FEI 309MG/COPPER N18680 001 NOV 15, 1984 MAR CAHN
>D> + POPULATION COUNCIL 309MG/COPPER N18680 001 NOV 15, 1984 MAR CAHN
CYCLOBENZAPRINE HYDROCHLORIDE
TABLET; ORAL
FLEXERIL
>D> @ MCNEIL CONS SPECLT 5MG N17821 001 MAR CMFD
>A> AA 5MG N17821 001 MAR CMFD
CYCLOSPORINE
EMULSION; OPHTHALMIC
RESTASIS
>A> + ALLERGAN 0.05% N50790 001 DEC 23, 2002 MAR CMS1
>D> 0.05% N50790 001 DEC 23, 2002 MAR CMS1
DEMECLOCYCLINE HYDROCHLORIDE
TABLET; ORAL
DECLOMYCIN
>D> @ LEDERLE 75MG N50261 001 MAR CAHN
>D> 150MG N50261 002 MAR CAHN
>D> + 300MG N50261 003 MAR CAHN
>A> @ WYETH PHARMS INC 75MG N50261 001 MAR CAHN
>A> 150MG N50261 002 MAR CAHN
>A> + 300MG N50261 003 MAR CAHN
DESOGESTREL; ETHINYL ESTRADIOL
TABLET; ORAL-21
>D> ORTHO-CEPT
>D> AB + ORTHO MCNEIL PHARM 0.15MG;0.03MG N20301 001 DEC 14, 1992 MAR DISC
>A> @ 0.15MG;0.03MG N20301 001 DEC 14, 1992 MAR DISC
TABLET; ORAL-28
>D> AB ORTHO MCNEIL PHARM 0.15MG;0.03MG N20301 002 DEC 14, 1992 MAR CRLD
>A> AB + 0.15MG;0.03MG N20301 002 DEC 14, 1992 MAR CRLD
DOXYCYCLINE HYCLATE
INJECTABLE; INJECTION
DOXY 100
>D> AP AM PHARM PARTNERS EQ 100MG BASE/VIAL N62475 001 DEC 09, 1983 MAR CRLD
>A> + EQ 100MG BASE/VIAL N62475 001 DEC 09, 1983 MAR CRLD
DOXY 200
>D> AP AM PHARM PARTNERS EQ 200MG BASE/VIAL N62475 002 DEC 09, 1983 MAR CRLD
>A> + EQ 200MG BASE/VIAL N62475 002 DEC 09, 1983 MAR CRLD
>D> VIBRAMYCIN
>D> AP + PFIZER EQ 100MG BASE/VIAL N50442 002 MAR DISC
>A> @ EQ 100MG BASE/VIAL N50442 002 MAR DISC
>D> AP + EQ 200MG BASE/VIAL N50442 001 MAR DISC
>A> @ EQ 200MG BASE/VIAL N50442 001 MAR DISC
ELETRIPTAN HYDROBROMIDE
TABLET; ORAL
RELPAX
>D> PFIZER EQ 20MG BASE N21016 001 DEC 26, 2002 MAR CAHN
>D> + EQ 40MG BASE N21016 002 DEC 26, 2002 MAR CAHN
>A> PFIZER IRELAND EQ 20MG BASE N21016 001 DEC 26, 2002 MAR CAHN
>A> + EQ 40MG BASE N21016 002 DEC 26, 2002 MAR CAHN
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
TABLET; ORAL
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
>A> AB IVAX PHARMS 5MG;12.5MG N75736 001 MAR 25, 2003 MAR NEWA
>A> AB 10MG;25MG N75736 002 MAR 25, 2003 MAR NEWA
>A> ENFUVIRTIDE
>A> INJECTABLE; SUBCUTANEOUS
>A> FUZEON
>A> + ROCHE 90MG/VIAL N21481 001 MAR 13, 2003 MAR NEWA
EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
DURANEST
>D> + DENTSPLY PHARM 0.005MG/ML;1.5% N21384 001 MAR DISC
>A> @ 0.005MG/ML;1.5% N21384 001 MAR DISC
ERGOTAMINE TARTRATE
TABLET; SUBLINGUAL
ERGOMAR
>A> + HARVEST PHARMS 2MG N87693 001 FEB 24, 1983 MAR CAHN
>D> + NEW RIVER 2MG N87693 001 FEB 24, 1983 MAR CAHN
ESMOLOL HYDROCHLORIDE
INJECTABLE; INJECTION
>A> BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
>A> + BAXTER HLTHCARE CORP 2GM/100ML N19386 005 JAN 27, 2003 MAR NEWA
>A> BREVIBLOC IN PLASTIC CONTAINER
>A> + BAXTER HLTHCARE CORP 1GM/100ML N19386 004 FEB 16, 2001 MAR NEWA
>A> ESTRADIOL ACETATE
>A> INSERT, EXTENDED RELEASE; VAGINAL
>A> FEMRING
>A> GALEN LTD 0.05MG/24HR N21367 001 MAR 20, 2003 MAR NEWA
>A> + 0.1MG/24HR N21367 002 MAR 20, 2003 MAR NEWA
ESTROGENS, CONJUGATED
CREAM; TOPICAL, VAGINAL
PREMARIN
>D> + AYERST 0.625MG/GM N20216 001 MAR CAHN
>A> + WYETH PHARMS INC 0.625MG/GM N20216 001 MAR CAHN
INJECTABLE; INJECTION
>D> + WYETH AYERST 25MG/VIAL N10402 001 MAR CAHN
>A> + WYETH PHARMS INC 25MG/VIAL N10402 001 MAR CAHN
TABLET; ORAL
>D> WYETH AYERST 0.3MG N04782 003 MAR CAHN
>D> + 0.625MG N04782 004 MAR CAHN
>D> 0.9MG N04782 005 JAN 26, 1984 MAR CAHN
>D> + 1.25MG N04782 001 MAR CAHN
>D> 2.5MG N04782 002 MAR CAHN
>A> WYETH PHARMS INC 0.3MG N04782 003 MAR CAHN
>A> + 0.625MG N04782 004 MAR CAHN
>A> 0.9MG N04782 005 JAN 26, 1984 MAR CAHN
>A> + 1.25MG N04782 001 MAR CAHN
>A> 2.5MG N04782 002 MAR CAHN
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
TABLET; ORAL-28
PREMPHASE (PREMARIN;CYCRIN 14/14)
>D> @ WYETH AYERST 0.625MG,0.625MG;5MG N20303 002 DEC 30, 1994 MAR CAHN
>A> @ WYETH PHARMS INC 0.625MG,0.625MG;5MG N20303 002 DEC 30, 1994 MAR CAHN
PREMPHASE 14/14
>D> + WYETH AYERST 0.625MG,0.625MG;5MG N20527 002 NOV 17, 1995 MAR CAHN
>A> + WYETH PHARMS INC 0.625MG,0.625MG;5MG N20527 002 NOV 17, 1995 MAR CAHN
PREMPRO
>D> + WYETH AYERST 0.625MG,0.625MG;2.5MG,2.5MG N20527 001 NOV 17, 1995 MAR CAHN
>D> + 0.625MG,0.625MG;5MG,5MG N20527 003 JAN 09, 1998 MAR CAHN
>A> + WYETH PHARMS INC 0.45MG;1.5MG N20527 004 MAR 12, 2003 MAR NEWA
>A> + 0.625MG,0.625MG;2.5MG,2.5MG N20527 001 NOV 17, 1995 MAR CAHN
>A> + 0.625MG,0.625MG;5MG,5MG N20527 003 JAN 09, 1998 MAR CAHN
PREMPRO (PREMARIN;CYCRIN)
>D> @ WYETH AYERST 0.625MG,0.625MG;2.5MG,2.5MG N20303 001 DEC 30, 1994 MAR CAHN
>A> @ WYETH PHARMS INC 0.625MG,0.625MG;2.5MG,2.5MG N20303 001 DEC 30, 1994 MAR CAHN
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL-21
ALESSE
>D> AB1 + WYETH AYERST 0.02MG;0.1MG N20683 001 MAR 27, 1997 MAR CAHN
>A> AB1 + WYETH PHARMS INC 0.02MG;0.1MG N20683 001 MAR 27, 1997 MAR CAHN
NORDETTE-21
>D> AB + WYETH AYERST 0.03MG;0.15MG N18668 001 MAY 10, 1982 MAR CAHN
>A> AB + WYETH PHARMS INC 0.03MG;0.15MG N18668 001 MAY 10, 1982 MAR CAHN
TRIPHASIL-21
>D> AB + WYETH AYERST 0.03MG,0.04MG,0.03MG;0.05MG,0.125MG
,0.075MG N19192 001 NOV 01, 1984 MAR CAHN
>A> AB + WYETH PHARMS INC 0.03MG,0.04MG,0.03MG;0.05MG,0.125MG
,0.075MG N19192 001 NOV 01, 1984 MAR CAHN
TABLET; ORAL-28
ALESSE
>D> AB1 WYETH AYERST 0.02MG;0.1MG N20683 002 MAR 27, 1997 MAR CAHN
>A> AB1 WYETH PHARMS INC 0.02MG;0.1MG N20683 002 MAR 27, 1997 MAR CAHN
NORDETTE-28
>D> AB WYETH AYERST 0.03MG;0.15MG N18782 001 JUL 21, 1982 MAR CAHN
>A> AB WYETH PHARMS INC 0.03MG;0.15MG N18782 001 JUL 21, 1982 MAR CAHN
TRIPHASIL-28
>D> AB WYETH AYERST 0.03MG,0.04MG,0.03MG;0.05MG,0.125MG
,0.075MG N19190 001 NOV 01, 1984 MAR CAHN
>A> AB WYETH PHARMS INC 0.03MG,0.04MG,0.03MG;0.05MG,0.125MG
,0.075MG N19190 001 NOV 01, 1984 MAR CAHN
ETHINYL ESTRADIOL; NORETHINDRONE
TABLET; ORAL-21
TRI-NORINYL 21-DAY
>D> @ WATSON LABS 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0
.5MG N18977 001 APR 13, 1984 MAR CPOT
>A> @ 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0
.5MG N18977 001 APR 13, 1984 MAR CPOT
TABLET; ORAL-28
TRI-NORINYL 28-DAY
>D> + WATSON LABS 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0
.5MG N18977 002 APR 13, 1984 MAR CPOT
>A> + 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0
.5MG N18977 002 APR 13, 1984 MAR CPOT
ETHINYL ESTRADIOL; NORGESTREL
TABLET; ORAL-21
LO/OVRAL
>D> AB + WYETH AYERST 0.03MG;0.3MG N17612 001 MAR CAHN
>A> AB + WYETH PHARMS INC 0.03MG;0.3MG N17612 001 MAR CAHN
OVRAL
>D> AB + WYETH AYERST 0.05MG;0.5MG N16672 001 MAR CAHN
>A> AB + WYETH PHARMS INC 0.05MG;0.5MG N16672 001 MAR CAHN
TABLET; ORAL-28
LO/OVRAL-28
>D> AB WYETH AYERST 0.03MG;0.3MG N17802 001 MAR CAHN
>A> AB WYETH PHARMS INC 0.03MG;0.3MG N17802 001 MAR CAHN
OVRAL-28
>D> AB WYETH AYERST 0.05MG;0.5MG N16806 001 MAR CAHN
>A> AB WYETH PHARMS INC 0.05MG;0.5MG N16806 001 MAR CAHN
ETHIONAMIDE
TABLET; ORAL
TRECATOR-SC
>D> + WYETH AYERST 250MG N13026 002 MAR CAHN
>A> + WYETH PHARMS INC 250MG N13026 002 MAR CAHN
ETHOTOIN
TABLET; ORAL
PEGANONE
>D> + ABBOTT 250MG N10841 001 MAR CAHN
>D> @ 500MG N10841 003 MAR CAHN
>A> + OVATION PHARMS 250MG N10841 001 MAR CAHN
>A> @ 500MG N10841 003 MAR CAHN
ETODOLAC
CAPSULE; ORAL
LODINE
>D> AB WYETH AYERST 200MG N18922 002 JAN 31, 1991 MAR CAHN
>D> AB + 300MG N18922 003 JAN 31, 1991 MAR CAHN
>A> AB WYETH PHARMS INC 200MG N18922 002 JAN 31, 1991 MAR CAHN
>A> AB + 300MG N18922 003 JAN 31, 1991 MAR CAHN
TABLET; ORAL
>D> AB WYETH AYERST 400MG N18922 004 JUL 29, 1993 MAR CAHN
>D> AB + 500MG N18922 005 JUN 28, 1996 MAR CAHN
>A> AB WYETH PHARMS INC 400MG N18922 004 JUL 29, 1993 MAR CAHN
>A> AB + 500MG N18922 005 JUN 28, 1996 MAR CAHN
TABLET, EXTENDED RELEASE; ORAL
ETODOLAC
>A> AB TARO 400MG N76174 001 MAR 13, 2003 MAR NEWA
>A> AB 500MG N76174 002 MAR 13, 2003 MAR NEWA
>A> AB 600MG N76174 003 MAR 13, 2003 MAR NEWA
LODINE XL
>D> AB + WYETH AYERST 400MG N20584 001 OCT 25, 1996 MAR CAHN
>D> AB + 500MG N20584 003 JAN 20, 1998 MAR CAHN
>D> AB + 600MG N20584 002 OCT 25, 1996 MAR CAHN
>A> AB + WYETH PHARMS INC 400MG N20584 001 OCT 25, 1996 MAR CAHN
>A> AB + 500MG N20584 003 JAN 20, 1998 MAR CAHN
>A> AB + 600MG N20584 002 OCT 25, 1996 MAR CAHN
FELBAMATE
SUSPENSION; ORAL
FELBATOL
>A> + MEDPOINTE 600MG/5ML N20189 003 JUL 29, 1993 MAR CAHN
>D> + WALLACE LABS 600MG/5ML N20189 003 JUL 29, 1993 MAR CAHN
TABLET; ORAL
>A> MEDPOINTE 400MG N20189 001 JUL 29, 1993 MAR CAHN
>A> + 600MG N20189 002 JUL 29, 1993 MAR CAHN
>D> WALLACE LABS 400MG N20189 001 JUL 29, 1993 MAR CAHN
>D> + 600MG N20189 002 JUL 29, 1993 MAR CAHN
FENOFIBRATE
CAPSULE; ORAL
FENOFIBRATE (MICRONIZED)
>D> AB TEVA 67MG N75753 001 SEP 03, 2002 MAR CTEC
>A> 67MG N75753 001 SEP 03, 2002 MAR CTEC
>D> AB 134MG N75753 002 APR 09, 2002 MAR CTEC
>A> 134MG N75753 002 APR 09, 2002 MAR CTEC
>D> AB 200MG N75753 003 APR 09, 2002 MAR CRLD
>A> + 200MG N75753 003 APR 09, 2002 MAR CRLD
>D> TRICOR (MICRONIZED)
>D> AB ABBOTT 67MG N19304 002 FEB 09, 1998 MAR DISC
>A> @ 67MG N19304 002 FEB 09, 1998 MAR DISC
>D> AB 134MG N19304 003 JUN 30, 1999 MAR DISC
>A> @ 134MG N19304 003 JUN 30, 1999 MAR DISC
>D> AB + 200MG N19304 004 JUN 30, 1999 MAR DISC
>A> @ 200MG N19304 004 JUN 30, 1999 MAR DISC
FLAVOXATE HYDROCHLORIDE
TABLET; ORAL
URISPAS
>D> + GLAXOSMITHKLINE 100MG N16769 001 MAR CAHN
>A> + ORTHO-MCNEIL PHARMAC 100MG N16769 001 MAR CAHN
FLECAINIDE ACETATE
TABLET; ORAL
FLECAINIDE ACETATE
>A> AB RANBAXY 50MG N76421 001 MAR 28, 2003 MAR NEWA
>A> AB 100MG N76421 002 MAR 28, 2003 MAR NEWA
>A> AB 150MG N76421 003 MAR 28, 2003 MAR NEWA
FOLIC ACID
INJECTABLE; INJECTION
FOLVITE
>D> AP + LEDERLE 5MG/ML N05897 008 MAR CAHN
>A> AP + WYETH PHARMS INC 5MG/ML N05897 008 MAR CAHN
TABLET; ORAL
>D> @ LEDERLE 1MG N05897 004 MAR CAHN
>A> @ WYETH PHARMS INC 1MG N05897 004 MAR CAHN
GATIFLOXACIN
>A> SOLUTION/DROPS; OPHTHALMIC
>A> ZYMAR
>A> + ALLERGAN 0.3% N21493 001 MAR 28, 2003 MAR NEWA
GEMTUZUMAB OZOGAMICIN
INJECTABLE; INJECTION
MYLOTARG
>D> + WYETH AYERST 5MG/VIAL N21174 001 MAY 17, 2000 MAR CAHN
>A> + WYETH PHARMS INC 5MG/VIAL N21174 001 MAY 17, 2000 MAR CAHN
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
TABLET; ORAL
INDERIDE-40/25
>D> AB WYETH AYERST 25MG;40MG N18031 001 MAR CAHN
>A> AB WYETH PHARMS INC 25MG;40MG N18031 001 MAR CAHN
INDERIDE-80/25
>D> AB + WYETH AYERST 25MG;80MG N18031 002 MAR CAHN
>A> AB + WYETH PHARMS INC 25MG;80MG N18031 002 MAR CAHN
IPRATROPIUM BROMIDE
SPRAY, METERED; NASAL
ATROVENT
>D> + BOEHRINGER INGELHEIM 0.021MG/SPRAY N20393 001 OCT 20, 1995 MAR CFTG
>A> AB + 0.021MG/SPRAY N20393 001 OCT 20, 1995 MAR CFTG
>D> + 0.042MG/SPRAY N20394 001 OCT 20, 1995 MAR CFTG
>A> AB + 0.042MG/SPRAY N20394 001 OCT 20, 1995 MAR CFTG
>A> IPRATROPIUM BROMIDE
>A> AB BAUSCH AND LOMB 0.021MG/SPRAY N76025 001 MAR 31, 2003 MAR NEWA
>A> AB 0.042MG/SPRAY N76103 001 MAR 31, 2003 MAR NEWA
>A> AB DEY 0.021MG/SPRAY N75552 001 MAR 31, 2003 MAR NEWA
>A> AB 0.042MG/SPRAY N75553 001 MAR 31, 2003 MAR NEWA
ISOSORBIDE DINITRATE
TABLET; ORAL
ISORDIL
>D> AB WYETH AYERST 5MG N12093 007 JUL 29, 1988 MAR CAHN
>D> AB 10MG N12093 002 JUL 29, 1988 MAR CAHN
>D> AB 20MG N12093 006 JUL 29, 1988 MAR CAHN
>D> AB + 30MG N12093 005 JUL 29, 1988 MAR CAHN
>D> AB 40MG N12093 001 JUL 29, 1988 MAR CAHN
>A> AB WYETH PHARMS INC 5MG N12093 007 JUL 29, 1988 MAR CAHN
>A> AB 10MG N12093 002 JUL 29, 1988 MAR CAHN
>A> AB 20MG N12093 006 JUL 29, 1988 MAR CAHN
>A> AB + 30MG N12093 005 JUL 29, 1988 MAR CAHN
>A> AB 40MG N12093 001 JUL 29, 1988 MAR CAHN
TABLET; SUBLINGUAL
>D> AB WYETH AYERST 2.5MG N12940 004 JUL 29, 1988 MAR CAHN
>D> AB 5MG N12940 003 JUL 29, 1988 MAR CAHN
>D> + 10MG N12940 005 JUL 29, 1988 MAR CAHN
>A> AB WYETH PHARMS INC 2.5MG N12940 004 JUL 29, 1988 MAR CAHN
>A> AB 5MG N12940 003 JUL 29, 1988 MAR CAHN
>A> + 10MG N12940 005 JUL 29, 1988 MAR CAHN
KETOPROFEN
CAPSULE, EXTENDED RELEASE; ORAL
ORUVAIL
>D> AB WYETH AYERST 100MG N19816 003 FEB 08, 1995 MAR CAHN
>D> AB 150MG N19816 002 FEB 08, 1995 MAR CAHN
>D> AB + 200MG N19816 001 SEP 24, 1993 MAR CAHN
>A> AB WYETH PHARMS INC 100MG N19816 003 FEB 08, 1995 MAR CAHN
>A> AB 150MG N19816 002 FEB 08, 1995 MAR CAHN
>A> AB + 200MG N19816 001 SEP 24, 1993 MAR CAHN
LACTULOSE
SOLUTION; ORAL
LACTULOSE
>D> AA LACHMAN CONSULT 10GM/15ML N74138 001 SEP 30, 1992 MAR CAHN
>A> AA VISTAPHARM 10GM/15ML N74138 001 SEP 30, 1992 MAR CAHN
LEFLUNOMIDE
TABLET; ORAL
ARAVA
>D> AVENTIS PHARMS 20MG N20905 002 SEP 10, 1998 MAR CRLD
>A> + 20MG N20905 002 SEP 10, 1998 MAR CRLD
>D> + 100MG N20905 003 SEP 10, 1998 MAR DISC
>A> @ 100MG N20905 003 SEP 10, 1998 MAR DISC
LEVOBETAXOLOL HYDROCHLORIDE
SUSPENSION/DROPS; OPHTHALMIC
BETAXON
>D> + ALCON EQ 0.5% BASE N21114 001 FEB 23, 2000 MAR CAHN
>A> + MEDPOINTE EQ 0.5% BASE N21114 001 FEB 23, 2000 MAR CAHN
LEVONORGESTREL
IMPLANT; IMPLANTATION
LEVONORGESTREL
>D> BX + WYETH AYERST 75MG/IMPLANT N20627 001 AUG 15, 1996 MAR CAHN
>A> BX + WYETH PHARMS INC 75MG/IMPLANT N20627 001 AUG 15, 1996 MAR CAHN
NORPLANT SYSTEM IN PLASTIC CONTAINER
>D> + WYETH AYERST 36MG/IMPLANT N20088 001 DEC 10, 1990 MAR CAHN
>A> + WYETH PHARMS INC 36MG/IMPLANT N20088 001 DEC 10, 1990 MAR CAHN
METHOCARBAMOL
TABLET; ORAL
METHOCARBAMOL
>A> AA ABLE 500MG N40413 001 MAR 17, 2003 MAR NEWA
>A> AA 750MG N40413 002 MAR 17, 2003 MAR NEWA
>A> AA LANNETT 500MG N84756 002 MAR 31, 2003 MAR NEWA
METHOTREXATE SODIUM
INJECTABLE; INJECTION
METHOTREXATE LPF
>D> AP + LEDERLE EQ 25MG BASE/ML N11719 007 MAR 31, 1982 MAR CAHN
>A> AP + WYETH PHARMS INC EQ 25MG BASE/ML N11719 007 MAR 31, 1982 MAR CAHN
METHOTREXATE SODIUM
>D> @ LEDERLE EQ 2.5MG BASE/ML N11719 004 MAR CAHN
>D> + EQ 20MG BASE/VIAL N11719 001 MAR CAHN
>D> AP + EQ 25MG BASE/ML N11719 005 MAR CAHN
>D> @ EQ 50MG BASE/VIAL N11719 003 MAR CAHN
>D> @ EQ 100MG BASE/VIAL N11719 006 MAR CAHN
>A> @ WYETH PHARMS INC EQ 2.5MG BASE/ML N11719 004 MAR CAHN
>A> + EQ 20MG BASE/VIAL N11719 001 MAR CAHN
>A> AP + EQ 25MG BASE/ML N11719 005 MAR CAHN
>A> @ EQ 50MG BASE/VIAL N11719 003 MAR CAHN
>A> @ EQ 100MG BASE/VIAL N11719 006 MAR CAHN
METHOTREXATE SODIUM PRESERVATIVE FREE
>D> AP + LEDERLE EQ 1GM BASE/VIAL N11719 009 APR 07, 1988 MAR CAHN
>A> AP + WYETH PHARMS INC EQ 1GM BASE/VIAL N11719 009 APR 07, 1988 MAR CAHN
METHSCOPOLAMINE BROMIDE
TABLET; ORAL
PAMINE FORTE
>A> + BRADLEY PHARMS 5MG N08848 002 MAR 25, 2003 MAR NEWA
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL
MINOCIN
>D> AB LEDERLE EQ 50MG BASE N50649 001 MAY 31, 1990 MAR CAHN
>D> AB EQ 75MG BASE N50649 003 FEB 12, 2001 MAR CAHN
>D> AB + EQ 100MG BASE N50649 002 MAY 31, 1990 MAR CAHN
>A> AB WYETH PHARMS INC EQ 50MG BASE N50649 001 MAY 31, 1990 MAR CAHN
>A> AB EQ 75MG BASE N50649 003 FEB 12, 2001 MAR CAHN
>A> AB + EQ 100MG BASE N50649 002 MAY 31, 1990 MAR CAHN
INJECTABLE; INJECTION
>D> + LEDERLE EQ 100MG BASE/VIAL N50444 001 MAR CAHN
>A> + WYETH PHARMS INC EQ 100MG BASE/VIAL N50444 001 MAR CAHN
NAPROXEN SODIUM
TABLET, EXTENDED RELEASE; ORAL
NAPRELAN
>D> + ELAN PHARM EQ 500MG BASE N20353 002 JAN 05, 1996 MAR CFTG
>A> AB + EQ 500MG BASE N20353 002 JAN 05, 1996 MAR CFTG
>A> NAPROXEN SODIUM
>A> AB ANDRX PHARMS EQ 500MG BASE N75416 001 AUG 27, 2002 MAR NEWA
NITROFURAZONE
OINTMENT; TOPICAL
>D> FURACIN
>D> + SHIRE PHARM 0.2% N05795 001 MAR DISC
>A> @ 0.2% N05795 001 MAR DISC
NOREPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
LEVOPHED
>D> + ABBOTT EQ 1MG BASE/ML N07513 001 MAR CFTG
>A> AP + EQ 1MG BASE/ML N07513 001 MAR CFTG
>A> NOREPINEPHRINE BITARTRATE
>A> AP GENSIA SICOR PHARMS EQ 1MG BASE/ML N40455 001 MAR 03, 2003 MAR NEWA
NORETHINDRONE ACETATE
TABLET; ORAL
AYGESTIN
>D> AB + WYETH AYERST 5MG N18405 001 APR 21, 1982 MAR CAHN
>A> AB + WYETH PHARMS INC 5MG N18405 001 APR 21, 1982 MAR CAHN
NORGESTREL
TABLET; ORAL
OVRETTE
>D> + WYETH AYERST 0.075MG N17031 001 MAR CAHN
>A> + WYETH PHARMS INC 0.075MG N17031 001 MAR CAHN
ORPHENADRINE CITRATE
INJECTABLE; INJECTION
ORPHENADRINE CITRATE
>A> AP BEDFORD LABS 30MG/ML N40463 001 MAR 04, 2003 MAR NEWA
PANTOPRAZOLE SODIUM
INJECTABLE; IV (INFUSION)
PROTONIX IV
>D> + WYETH AYERST EQ 40MG BASE/VIAL N20988 001 MAR 22, 2001 MAR CAHN
>A> + WYETH PHARMS INC EQ 40MG BASE/VIAL N20988 001 MAR 22, 2001 MAR CAHN
TABLET, DELAYED RELEASE; ORAL
PROTONIX
>D> + WYETH AYERST EQ 20MG BASE N20987 002 JUN 12, 2001 MAR CAHN
>D> + EQ 40MG BASE N20987 001 FEB 02, 2000 MAR CAHN
>A> + WYETH PHARMS INC EQ 20MG BASE N20987 002 JUN 12, 2001 MAR CAHN
>A> + EQ 40MG BASE N20987 001 FEB 02, 2000 MAR CAHN
>A> PEGVISOMANT
>A> INJECTABLE; SUBCUTANEOUS
>A> SOMAVERT
>A> + PHARMACIA AND UPJOHN 10MG/VIAL N21106 001 MAR 25, 2003 MAR NEWA
>A> + 15MG/VIAL N21106 002 MAR 25, 2003 MAR NEWA
>A> + 20MG/VIAL N21106 003 MAR 25, 2003 MAR NEWA
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HCL
>A> AA ABLE 15MG N40497 001 MAR 13, 2003 MAR NEWA
PHENYTOIN
SUSPENSION; ORAL
PHENYTOIN
>D> AB UDL 125MG/5ML N40342 001 JAN 31, 2001 MAR CAHN
>A> AB VISTAPHARM 125MG/5ML N40342 001 JAN 31, 2001 MAR CAHN
PHENYTOIN SODIUM
INJECTABLE; INJECTION
>D> DILANTIN
>D> @ PARKE DAVIS 50MG/ML N10151 001 MAR DISC
>A> @ 50MG/ML N10151 001 MAR DISC
PHENYTOIN
>D> AP ELKINS SINN 50MG/ML N84307 001 MAR CRLD
>A> + 50MG/ML N84307 001 MAR CRLD
>D> PHENYTOIN SODIUM
>D> AP ABBOTT 50MG/ML N89521 001 MAR 17, 1987 MAR DISC
>A> @ 50MG/ML N89521 001 MAR 17, 1987 MAR DISC
>D> AP 50MG/ML N89744 001 DEC 18, 1987 MAR DISC
>A> @ 50MG/ML N89744 001 DEC 18, 1987 MAR DISC
PIPERACILLIN SODIUM
INJECTABLE; INJECTION
PIPRACIL
>D> + LEDERLE EQ 2GM BASE/VIAL N50545 002 MAR CAHN
>D> EQ 2GM BASE/VIAL N62750 001 OCT 13, 1987 MAR CAHN
>D> + EQ 3GM BASE/VIAL N50545 003 MAR CAHN
>D> EQ 3GM BASE/VIAL N62750 002 OCT 13, 1987 MAR CAHN
>D> + EQ 4GM BASE/VIAL N50545 004 MAR CAHN
>D> EQ 4GM BASE/VIAL N62750 003 OCT 13, 1987 MAR CAHN
>D> @ EQ 40GM BASE/VIAL N50545 006 SEP 30, 1985 MAR CAHN
>A> + WYETH PHARMS INC EQ 2GM BASE/VIAL N50545 002 MAR CAHN
>A> EQ 2GM BASE/VIAL N62750 001 OCT 13, 1987 MAR CAHN
>A> + EQ 3GM BASE/VIAL N50545 003 MAR CAHN
>A> EQ 3GM BASE/VIAL N62750 002 OCT 13, 1987 MAR CAHN
>A> + EQ 4GM BASE/VIAL N50545 004 MAR CAHN
>A> EQ 4GM BASE/VIAL N62750 003 OCT 13, 1987 MAR CAHN
>A> @ EQ 40GM BASE/VIAL N50545 006 SEP 30, 1985 MAR CAHN
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
INJECTABLE; INJECTION
ZOSYN
>D> + WYETH AYERST EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL N50684 001 OCT 22, 1993 MAR CAHN
>D> + EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL N50684 002 OCT 22, 1993 MAR CAHN
>D> + EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL N50684 003 OCT 22, 1993 MAR CAHN
>D> + EQ 36GM BASE/VIAL;EQ 4.5GM
BASE/VIAL N50684 004 OCT 22, 1993 MAR CAHN
>A> + WYETH PHARMS INC EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL N50684 001 OCT 22, 1993 MAR CAHN
>A> + EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL N50684 002 OCT 22, 1993 MAR CAHN
>A> + EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL N50684 003 OCT 22, 1993 MAR CAHN
>A> + EQ 36GM BASE/VIAL;EQ 4.5GM
BASE/VIAL N50684 004 OCT 22, 1993 MAR CAHN
ZOSYN IN PLASTIC CONTAINER
>D> + LEDERLE EQ 4GM BASE/100ML;EQ 500MG
BASE/100ML N50750 003 FEB 24, 1998 MAR CAHN
>D> + EQ 40MG BASE/ML;EQ 5MG BASE/ML N50750 001 FEB 24, 1998 MAR CAHN
>D> + EQ 60MG BASE/ML;EQ 7.5MG BASE/ML N50750 002 FEB 24, 1998 MAR CAHN
>A> + WYETH PHARMS INC EQ 40MG BASE/ML;EQ 5MG BASE/ML N50750 001 FEB 24, 1998 MAR CAHN
>A> + EQ 60MG BASE/ML;EQ 7.5MG BASE/ML N50750 002 FEB 24, 1998 MAR CAHN
>A> + EQ 4GM BASE/100ML;EQ 500MG
BASE/100ML N50750 003 FEB 24, 1998 MAR CAHN
PRALIDOXIME CHLORIDE
INJECTABLE; INJECTION
PRALIDOXIME CHLORIDE
>A> @ BAXTER HLTHCARE CORP 300MG/ML N18799 001 DEC 13, 1982 MAR CAHN
>D> @ WYETH AYERST 300MG/ML N18799 001 DEC 13, 1982 MAR CAHN
PREDNISOLONE
SYRUP; ORAL
PREDNISOLONE
>A> AA PHARM ASSOC 15MG/5ML N40399 001 MAR 05, 2003 MAR NEWA
PREDNISOLONE SODIUM PHOSPHATE
SOLUTION; ORAL
PREDNISOLONE SODIUM PHOSPHATE
>A> AA HI TECH PHARMA EQ 5MG BASE/5ML N75183 001 MAR 26, 2003 MAR NEWA
PROMETHAZINE HYDROCHLORIDE
INJECTABLE; INJECTION
PROMETHAZINE HCL
>A> AP PHARMAFORCE 25MG/ML N40515 001 MAR 19, 2003 MAR NEWA
SUPPOSITORY; RECTAL
PHENERGAN
>D> WYETH AYERST 12.5MG N10926 002 MAR CAHN
>D> AB + 25MG N10926 001 MAR CAHN
>D> AB + 50MG N11689 001 MAR CAHN
>A> AB WYETH PHARMS INC 12.5MG N10926 002 MAR CAHN
>A> AB + 25MG N10926 001 MAR CAHN
>A> AB + 50MG N11689 001 MAR CAHN
>A> PROMETHAZINE HCL
>A> AB G AND W LABS 12.5MG N40428 002 MAR 31, 2003 MAR NEWA
TABLET; ORAL
PHENERGAN
>D> WYETH AYERST 12.5MG N07935 002 MAR CAHN
>D> BP 25MG N07935 003 MAR CAHN
>D> BP + 50MG N07935 004 MAR CAHN
>A> WYETH PHARMS INC 12.5MG N07935 002 MAR CAHN
>A> BP 25MG N07935 003 MAR CAHN
>A> BP + 50MG N07935 004 MAR CAHN
PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
INDERAL LA
>D> WYETH AYERST 60MG N18553 004 MAR 18, 1987 MAR CAHN
>D> 80MG N18553 002 APR 19, 1983 MAR CTEC
>D> 120MG N18553 003 APR 19, 1983 MAR CTEC
>D> + 160MG N18553 001 APR 19, 1983 MAR CAHN
>A> WYETH PHARMS INC 60MG N18553 004 MAR 18, 1987 MAR CAHN
>A> BX 80MG N18553 002 APR 19, 1983 MAR CTEC
>A> BX 120MG N18553 003 APR 19, 1983 MAR CTEC
>A> + 160MG N18553 001 APR 19, 1983 MAR CAHN
>A> INNOPRAN XL
>A> BX RELIANT PHARMS 80MG N21438 001 MAR 12, 2003 MAR NEWA
>A> BX 120MG N21438 002 MAR 12, 2003 MAR NEWA
TABLET; ORAL
INDERAL
>D> AB + WYETH AYERST 10MG N16418 001 MAR CAHN
>D> AB 20MG N16418 003 MAR CAHN
>D> AB 40MG N16418 002 MAR CAHN
>D> AB 60MG N16418 009 OCT 18, 1982 MAR CAHN
>D> AB + 80MG N16418 004 MAR CAHN
>D> @ 90MG N16418 010 OCT 18, 1982 MAR CAHN
>A> AB + WYETH PHARMS INC 10MG N16418 001 MAR CAHN
>A> AB 20MG N16418 003 MAR CAHN
>A> AB 40MG N16418 002 MAR CAHN
>A> AB 60MG N16418 009 OCT 18, 1982 MAR CAHN
>A> AB + 80MG N16418 004 MAR CAHN
>A> @ 90MG N16418 010 OCT 18, 1982 MAR CAHN
QUETIAPINE FUMARATE
TABLET; ORAL
SEROQUEL
>D> ASTRAZENECA EQ 25MG BASE N20639 001 SEP 26, 1997 MAR CRLD
>A> + EQ 25MG BASE N20639 001 SEP 26, 1997 MAR CRLD
QUINIDINE GLUCONATE
TABLET, EXTENDED RELEASE; ORAL
>D> QUINAGLUTE
>D> BX + BERLEX LABS 324MG N16647 001 MAR DISC
>A> @ 324MG N16647 001 MAR DISC
QUINIDINE GLUCONATE
>D> BX WATSON LABS 324MG N87810 001 SEP 29, 1982 MAR CRLD
>A> + 324MG N87810 001 SEP 29, 1982 MAR CRLD
QUINIDINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
QUINIDEX
>D> AB + ROBINS AH 300MG N12796 002 MAR CAHN
>A> AB + WYETH PHARMS INC 300MG N12796 002 MAR CAHN
SIROLIMUS
SOLUTION; ORAL
RAPAMUNE
>D> + WYETH AYERST 1MG/ML N21083 001 SEP 15, 1999 MAR CAHN
>A> + WYETH PHARMS INC 1MG/ML N21083 001 SEP 15, 1999 MAR CAHN
TABLET; ORAL
>D> + WYETH AYERST 1MG N21110 001 AUG 25, 2000 MAR CRLD
>A> WYETH PHARMS INC 1MG N21110 001 AUG 25, 2000 MAR CRLD
>A> + 2MG N21110 002 AUG 22, 2002 MAR NEWA
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION
>D> BIO-TROPIN
>D> + BIO TECH GEN 4.8MG/VIAL N19774 001 MAY 25, 1995 MAR DISC
>A> @ 4.8MG/VIAL N19774 001 MAY 25, 1995 MAR DISC
SOTALOL HYDROCHLORIDE
TABLET; ORAL
BETAPACE AF
>A> BERLEX LABS 100MG N21151 005 MAR 14, 2003 MAR NEWA
TAMOXIFEN CITRATE
TABLET; ORAL
TAMOXIFEN CITRATE
>A> AB AEGIS PHARMS EQ 10MG BASE N76398 001 MAR 31, 2003 MAR NEWA
>A> AB EQ 20MG BASE N76398 002 MAR 31, 2003 MAR NEWA
>A> AB TEVA EQ 10MG BASE N74539 001 MAR 31, 2003 MAR NEWA
TECHNETIUM TC-99M MEDRONATE KIT
INJECTABLE; INJECTION
TECHNESCAN MDP KIT
>D> AP DRAXIMAGE N/A N18035 001 MAR CRLD
>A> AP + N/A N18035 001 MAR CRLD
TIZANIDINE HYDROCHLORIDE
TABLET; ORAL
TIZANIDINE HCL
>A> AB MYLAN EQ 2MG BASE N76354 001 MAR 28, 2003 MAR NEWA
>A> AB EQ 4MG BASE N76354 002 MAR 28, 2003 MAR NEWA
TRAMADOL HYDROCHLORIDE
TABLET; ORAL
TRAMADOL HCL
>D> AB ABLE 50MG N75963 001 JUL 03, 2002 MAR CAHN
>A> AB IVAX PHARMS 50MG N75963 001 JUL 03, 2002 MAR CAHN
UREA, C-13
FOR SOLUTION; ORAL
PYLORI-CHEK BREATH TEST
>D> @ ALIMENTERICS 100MG/VIAL N20900 001 FEB 04, 1999 MAR CAHN
>A> @ DEVICES 100MG/VIAL N20900 001 FEB 04, 1999 MAR CAHN
VENLAFAXINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
EFFEXOR XR
>D> WYETH AYERST EQ 37.5MG BASE N20699 001 OCT 20, 1997 MAR CAHN
>D> + EQ 75MG BASE N20699 002 OCT 20, 1997 MAR CRLD
>D> @ EQ 100MG BASE N20699 003 OCT 20, 1997 MAR CAHN
>D> EQ 150MG BASE N20699 004 OCT 20, 1997 MAR CRLD
>A> WYETH PHARMS INC EQ 37.5MG BASE N20699 001 OCT 20, 1997 MAR CAHN
>A> EQ 75MG BASE N20699 002 OCT 20, 1997 MAR CRLD
>A> @ EQ 100MG BASE N20699 003 OCT 20, 1997 MAR CAHN
>A> + EQ 150MG BASE N20699 004 OCT 20, 1997 MAR CRLD
TABLET; ORAL
EFFEXOR
>D> @ WYETH AYERST EQ 12.5MG BASE N20151 001 DEC 28, 1993 MAR CAHN
>D> + EQ 25MG BASE N20151 002 DEC 28, 1993 MAR CRLD
>D> EQ 37.5MG BASE N20151 006 DEC 28, 1993 MAR CAHN
>D> EQ 50MG BASE N20151 003 DEC 28, 1993 MAR CAHN
>D> EQ 75MG BASE N20151 004 DEC 28, 1993 MAR CAHN
>D> + EQ 100MG BASE N20151 005 DEC 28, 1993 MAR CAHN
>A> @ WYETH PHARMS INC EQ 12.5MG BASE N20151 001 DEC 28, 1993 MAR CAHN
>A> EQ 25MG BASE N20151 002 DEC 28, 1993 MAR CRLD
>A> EQ 37.5MG BASE N20151 006 DEC 28, 1993 MAR CAHN
>A> EQ 50MG BASE N20151 003 DEC 28, 1993 MAR CAHN
>A> EQ 75MG BASE N20151 004 DEC 28, 1993 MAR CAHN
>A> + EQ 100MG BASE N20151 005 DEC 28, 1993 MAR CAHN
ZOLEDRONIC ACID
INJECTABLE; IV (INFUSION)
ZOMETA
>A> + NOVARTIS EQ 4MG BASE/5ML N21223 002 MAR 07, 2003 MAR NEWA
ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE
TABLET, CHEWABLE; ORAL
FOAMICON
>D> GENEVA PHARMS TECH 80MG;20MG N72687 001 JUN 28, 1989 MAR CAHN
>A> NOVARTIS 80MG;20MG N72687 001 JUN 28, 1989 MAR CAHN
>D> CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
>D> CAPSULE, EXTENDED RELEASE; ORAL
>D> PSEUDOEPHEDRINE HCL AND CHLORPHENIRAMINE MALEATE
>D> + CENT PHARMS 8MG;120MG N19428 001 AUG 02, 1988 MAR DISC
>A> @ 8MG;120MG N19428 001 AUG 02, 1988 MAR DISC
CIMETIDINE
TABLET; ORAL
CIMETIDINE
>D> LEK PHARM 100MG N75122 001 JUN 19, 1998 MAR CAHN
>D> 200MG N75122 002 JUN 19, 1998 MAR CAHN
>A> @ LEK PHARMS 100MG N75122 001 JUN 19, 1998 MAR CAHN
>A> 200MG N75122 002 JUN 19, 1998 MAR CAHN
LORATADINE
SYRUP; ORAL
CLARITIN
>A> SCHERING 1MG/ML N20641 002 NOV 27, 2002 MAR NEWA
TABLET; ORAL
>A> SCHERING 10MG N19658 002 NOV 27, 2002 MAR NEWA
TABLET, ORALLY DISINTEGRATING; ORAL
CLARITIN REDITABS
>A> SCHERING 10MG N20704 002 NOV 27, 2002 MAR NEWA
LORATADINE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
CLARITIN-D
>A> SCHERING 5MG;120MG N19670 002 NOV 27, 2002 MAR NEWA
CLARITIN-D 24 HOUR
>A> SCHERING 10MG;240MG N20470 002 NOV 27, 2002 MAR NEWA
PERMETHRIN
LOTION; TOPICAL
NIX
>A> + INSIGHT PHARMS 1% N19918 001 MAY 02, 1990 MAR CAHN
>D> + WARNER LAMBERT 1% N19918 001 MAY 02, 1990 MAR CAHN
Back to Top 
Product List Archive
FDA/Center for Drug Evaluation and Research
Last Updated: March 18, 2003
Originator: OIT/DDMS
HTML by PKS